Experimental drug aims to tame uncontrollable seizures
NCT ID NCT06377930
Summary
This study tested whether an investigational drug called RAP-219 can safely reduce seizures in adults with focal epilepsy that doesn't respond well to standard medications. About 30 participants, who already had a special brain-stimulation device implanted, took the drug to see if it lowered their seizure frequency. Researchers measured changes in seizure counts and monitored for side effects over the treatment period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL ONSET SEIZURES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Baylor College of Medicine
Houston, Texas, 770300, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Consultants in Epilepsy and Neurology, PLLC
Boise, Idaho, 83702, United States
-
IU Health Neuroscience Center, Goodman Hall
Indianapolis, Indiana, 46202, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
NYU Langone Comprehensive Epilepsy Center
New York, New York, 10016, United States
-
The University of Kansas Medical Center Epilepsy Clinic
Kansas City, Kansas, 66160, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Pennsylvania - Department of Neurology
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas Health Science Center, Houston
Houston, Texas, 77030, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Yale University
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.